In The Middle Of The Ozempic Gold Rush Habitual Refused the “Easy” Revenue: We Find Out Why
Tech Talks11 Helmi

In The Middle Of The Ozempic Gold Rush Habitual Refused the “Easy” Revenue: We Find Out Why

GLP-1 medications like Ozempic and Mounjaro have changed the world, but they aren't a silver bullet.

Napala Pratini, co-founder of Habitual, joins David to discuss the “hard stuff” behind the hype: behavior change, side effects, and the ethics of digital health. She reveals why her company turned down the chance to just “stack drugs high and sell them cheap” and opens up about the isolation of the “toxic founder cult.”


WhatsApp us on +447392087344

Want to read the latest from David, his Substack (diving into ‘Tech Talks’ and more) is here.

Tech Talks is powered by Nash Squared, the leading global provider of technology and talent solutions. Click here to learn more about our services.

The music on Tech Talks is created by London artist Lemzi.

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(892)

This Chief Marketing Officer Has Thrown Out a 20-Year Marketing Playbook: We Explore Why.

This Chief Marketing Officer Has Thrown Out a 20-Year Marketing Playbook: We Explore Why.

After 20 years in marketing, Klaviyo Chief Marketing Officer Jamie Domenici realised her traditional playbook was dead. In this episode, she reveals why she’s completely restructuring her teams to wor...

20 Heinä 27min

Ravi Malick Explains Why Measuring AI Usage Will Sabotage Your Rollout

Ravi Malick Explains Why Measuring AI Usage Will Sabotage Your Rollout

Many companies measure AI success by usage alone, but Box's CTO Ravi Malick says that's a trap that can sabotage your rollout, pushing teams to burn budgets just to look innovative.In this episode Rav...

17 Heinä 34min

Why This Venture Creator Builds Deep Tech Companies That Never Need to Pivot

Why This Venture Creator Builds Deep Tech Companies That Never Need to Pivot

In this episode, we explore the reality of building deep tech companies that solve massive societal problems. with cofouder and entrepreneur Dom Falcão.Deep Science Ventures challenges the traditional...

15 Heinä 32min

From Quantum Lab to VC: Rethinking Who Funds the Future

From Quantum Lab to VC: Rethinking Who Funds the Future

Ion Hauer didn’t plan to be a venture capitalist; he started in a quantum physics lab. Today, as a Principal at Apex Ventures, he uses scientific rigor to cut through deep tech hype. In this episode, ...

13 Heinä 31min

Why Your Team Treating AI Like a Human Continues to Harm AI Literacy

Why Your Team Treating AI Like a Human Continues to Harm AI Literacy

Generative AI sounds confident, but it's fundamentally probabilistic, more like a weather app than a calculator. In this episode, Dr. Pravi Devineni, Lead AI Scientist at Duke Energy, explains why ant...

10 Heinä 30min

Worried About Spiralling AI Costs? Don't Limit Spending, Follow Fiverr's Lead & Increase Visibility.

Worried About Spiralling AI Costs? Don't Limit Spending, Follow Fiverr's Lead & Increase Visibility.

When Fiverr's CTO Yossi Levin decided to equip his entire company with Al tools, he didn't set spending limits. Instead, he made cost visibility the only rule. In this episode, Yossi reveals the human...

8 Heinä 39min

The Truth About Agent Sprawl (And Why Bigger AI Isn't Always Better)

The Truth About Agent Sprawl (And Why Bigger AI Isn't Always Better)

Every app now offers an AI agent, leading to a new enterprise nightmare: "agent sprawl". In this episode, David sits down with Franny Hsiao, Salesforce’s EMEA AI Architects Lead, to unpack the hidden ...

6 Heinä 28min

Don't Let Science-Fiction Ruin Your Growth Strategy

Don't Let Science-Fiction Ruin Your Growth Strategy

In this episode, David sits down with Mick Costigan, who leads Salesforce Futures, to explore how leaders can anticipate and shape the future of technology. We unpack why AI "hallucinations" are actua...

3 Heinä 33min